Do you want to read an article? Please log in or register.
Low-Dose Valacyclovir in Herpes Zoster Ophthalmicus: The Zoster Eye Disease Randomized Clinical Trial
Further Publications
Related content
Further Publications
Low-Dose Valacyclovir for Postherpetic Neuralgia in the Zoster Eye Disease Study: A Randomized Clinical Trial
JAMA Ophthalmol
Warner DB, Jeng BH, Kim J, Liu M, Troxel AB, Hochman JS, Baratz KH, Mian SI, Choulakian MY, Meyer JJ, Lu Y, Twi-Yeboah A, Lee TF, Lopez-Jimenez C, Laury SC, Cohen EJ, ZEDS Trial Research Group
doi: 10.1001/jamaophthalmol.2024.6113
LensesFurther Publications
Capsular Tension Ring Implantation for Intraocular Lens Power Calculation in Highly Myopic Eyes: Secondary Analysis of a Randomized Clinical Trial
JAMA Ophthalmol
Lin H, Zhang J, Jin A, Zhang Y, Zhang Y, Jin L, Xu Y, Xie X, Qiu X, Dai B, Tan X, Luo L, Liu Y
doi: 10.1001/jamaophthalmol.2025.0110
Uveitis
Filgotinib in Active Noninfectious Uveitis: The HUMBOLDT Randomized Clinical Trial
JAMA Ophthalmol
Srivastava SK, Watkins TR, Nguyen QD, Sharma S, Scales DK, Dacey MS, Shah RE, Chu DS, Grewal DS, Faia LJ, Suhler EB, Genovese MC, Guo Y, Barchuk WT, Besuyen R, Dick AD, Rosenbaum JT
doi: 10.1001/jamaophthalmol.2024.2439
Macular Diseases
Tissue Plasminogen Activator or Perfluoropropane for Submacular Hemorrhage in Age-Related Macular Degeneration: A Factorial Randomized Clinical Trial
JAMA Ophthalmol
Murphy GSP, Saleh A, Ayis S, Cheema MR, Mehta A, Steel DH, Membrey L, Costen M, Jackson TL
doi: 10.1001/jamaophthalmol.2024.4297
RECOMMENDED
Macular DiseasesFurther Publications
Cocoa Flavanol Supplementation and Risk of Age-Related Macular Degeneration: An Ancillary Study of the COSMOS Randomized Clinical Trial
★ 1
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
JAMA Ophthalmol
Christen WG, Rist PM, Moorthy MV, Smith DC, Holman B, Clar A, Glynn RJ, Mares JA, Sobrin L, Shadyab AH, Allison MA, Millen AE, Manson JE, Sesso HD, COSMOS Research Group
doi: 10.1001/jamaophthalmol.2025.0353
Macular DiseasesRetinal Diseases
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study
Eye (Lond)
Puzo M, Calvo-Perez P, Bartol-Puyal F, Sanchez-Monroy J, Martin-Pinardel R, Parrado-Carrillo A, Moll-Udina A, Bernal-Morales C, Sanchez-Vela L, Sararols-Ramsay L, Garay-Aramburu G, Arruabarrena C, García-Arumí J, Abraldes M, Ruiz-Moreno JM, Valldeperas X, Velázquez-Villoria D, Escobar-Barranco JJ, Gallego-Pinazo R, Figueroa MS, Figueras-Roca M, Barthelmes D, Gillies MC, Casaroli-Marano RP, Zarranz-Ventura J, from the writing committee of the Fight Retinal Blindness Spain (FRB! Spain) Users Group
doi: 10.1038/s41433-024-03322-8
Further Publications
3-year results of 0.01% and 0.1% loading dose atropine treatment including washout in Danish children with myopia: a placebo-controlled, randomised clinical trial
Br J Ophthalmol
Hansen N, Hvid-Hansen A, Møller F, Bek T, Larsen D, Jacobsen N, Kessel L
doi: 10.1136/bjo-2024-326918
RECOMMENDED
Further Publications
Efficacy and Safety of Different Atropine Regimens for the Treatment of Myopia in Children: Three-Year Results of the MOSAIC Randomized Clinical Trial
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
JAMA Ophthalmol
Loughman J, Lingham G, Nkansah EK, Kobia-Acquah E, Flitcroft DI
doi: 10.1001/jamaophthalmol.2024.5703
Dry Eye Disease
Clinical practice patterns in the management of dry eye disease: A TFOS international survey 2023-4
Ocul Surf
Wolffsohn JS, Semp DA, Dutta D, Jones L, Craig JP, TFOS ambassadors
doi: 10.1016/j.jtos.2024.12.008